APA (7th ed.) Citation

Rugo, H. S., Bardia, A., Schmid, P., Tolaney, S. M., Dasgupta, A., Kaushik, A., . . . Marmé, F. (2025). Q-TWiST analysis of sacituzumab govitecan vs. chemotherapy in previously treated patients with HR+/HER2− metastatic breast cancer. Current oncology, 32(3), . https://doi.org/10.3390/curroncol32030169

Chicago Style (17th ed.) Citation

Rugo, Hope S., et al. "Q-TWiST Analysis of Sacituzumab Govitecan Vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer." Current Oncology 32, no. 3 (2025). https://doi.org/10.3390/curroncol32030169.

MLA (9th ed.) Citation

Rugo, Hope S., et al. "Q-TWiST Analysis of Sacituzumab Govitecan Vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer." Current Oncology, vol. 32, no. 3, 2025, https://doi.org/10.3390/curroncol32030169.